journal
Journal For International Medical Graduates
Journal For International Medical Graduates
California Institute of Behavioral Neurosciences and Psychology
US
https://www.cibnp.com
2832-9864
114
Articles
Cardiovascular Manifestations and Therapy Options for Systemic Lupus Erythematosus: A Systemic Literature Review
Hiba Nashat
Nashat
Hiba
hiba.nashat@jimgs.com
Sally Ghali
Ghali
Sally
sally.ghali@jimgs.com
Shadin Afif
Afif
Shadin
shadin.afif@jimgs.com
Vineet Suryadevara
Suryadevara
Vineet
vineet.suryadevara@jimgs.com
Yaman Habab
Habab
Yaman
yaman.habab@jimgs.com
Alana Hutcheson
Hutcheson
Alana
alana.hutcheson@jimgs.com
Binay Kumar Panjiyar
Panjiyar
Binay Kumar
binay.kumar.panjiyar@jimgs.com
Gershon Davydov
Davydov
Gershon
gershon.davydov@jimgs.com
Noor Abdulla
Abdulla
Noor
noor.abdulla@jimgs.com
Ann Kashmer Yu
Yu
Ann Kashmer
ann.kashmer.yu@jimgs.com
28
08
2023
Received: 2882023
Copyright (c) 2023 Journal For International Medical Graduates
2023
Journal For International Medical Graduates
SLE
Lupus
Discoid lupus erythematosus
Autoimmune disease
Hydroxychloroquine٠ Immune suppressive
Anti-malarial
Plaquenil
Pericarditis
Constrictive pericarditis
Diffuse ST elevation
Pericardiectomy
[
Larson NP, Frawley TC, Long B. Cardiac Tamponade in an-18-year-old Male with Undiagnosed Systemic Lupus Erythematosus. Cureus. 2019;11(7):e5186. Published 2019 Jul 21. doi:10.7759/cureus.5186
]
[
Marijanovich N, Halalau A. Hemorrhagic Tamponade as Initial Manifestation of Systemic Lupus with Subsequent Refractory and Progressive Lupus Myocarditis Resulting in Cardiomyopathy and Mitral Regurgitation. Case Rep Rheumatol. 2018; 2018:7635982. Published 2018 Jan 21. doi:10.1155/2018/7635982
]
[
Raval, J.J., Ruiz, C.R., Heywood, J. et al. SLE strikes the heart! A rare presentation of SLE myocarditis presenting as cardiogenic shock. BMC Cardiovasc Disord 21, 294 (2021). https://doi.org/10.1186/s12872-021-02102-6
]
[
Tariq S, Garg A, Gass A, Aronow WS. Myocarditis due to systemic lupus erythematosus associated with cardiogenic shock. Arch Med Sci. 2018;14(2):460-462. doi:10.5114/aoms.2017.68692
]
[
Ezat Amin, M., Elsayed, M., Mohammed, H., Abdel baset, A., Kasem, S. Cardiovascular System involvement in systemic lupus erythematosus (SLE). Sohag Medical Journal, 2021; 25(1): 18-22. doi: 10.21608/smj.2020.41302.1192
]
[
Thomas G, Cohen Aubart F, Chiche L, et al. Lupus Myocarditis: Initial Presentation and Longterm Outcomes in a Multicentric Series of 29 Patients. J Rheumatol. 2017;44(1):24-32. doi:10.3899/jrheum.160493
]
[
Zhang X, Wu W. Cardiac tamponade as the initial symptom due to systemic lupus erythematosus in a young man: A case report. Medicine (Baltimore). 2018;97(51): e13708. doi:10.1097/MD.0000000000013708
]
[
Jawaid A, Almas A. Cardiac tamponade as initial presentation in systemic lupus erythematosus. J Coll Physicians Surg Pak. 2014;24 Suppl 2: S138-S140.
]
[
Shimizu T, Murata M, Tomizawa H, Mitsuhashi T, Katsuki T, Shimada K. Systemic lupus erythematosus initially manifesting as acute pericarditis complicating with cardiac tamponade: a case report. J Cardiol. 2007;49(5):273-276.
]
[
Maharaj SS, Chang SM. Cardiac tamponade as the initial presentation of systemic lupus erythematosus: a case report and review of the literature. Pediatr Rheumatol Online J. 2015; 13:9. Published 2015 Mar 17. doi:10.1186/s12969-015-0005-0
]
[
Cheng W, Balachandar R, Mistry P. Cardiac tamponade: an initial presentation of SLE. BMJ Case Rep. 2013;2013: bcr2013200011. Published 2013 Jul 18. doi:10.1136/bcr-2013-200011
]
[
Umer A, Bhatti S, Jawed S. Sub-acute Cardiac Tamponade as an Early Clinical Presentation of Childhood Systemic Lupus Erythematosus: A Case Report. Cureus. 2018;10(10): e3478. Published 2018 Oct 22. doi:10.7759/cureus.3478
]
[
Li W, Frohwein T, Ong K. Cardiac tamponade as an initial presentation for systemic lupus erythematosus. Am J Emerg Med. 2017;35(8): 1213.e1-1213.e4. doi: 10.1016/j.ajem.2017.04.075
]
[
Murphy G, Isenberg D. Effect of gender on clinical presentation in systemic lupus erythematosus. Rheumatology, Volume 52, Issue 12, December 2013, Pages 2108–2115, doi.org/10.1093/rheumatology/ket160
]
[
Meridor K, Shoenfeld Y, Tayer-Shifman O, Levy Y. Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment: Case series and literature review. Medicine (Baltimore). 2021;100(18): e25591. doi:10.1097/MD.0000000000025591
]
[
PRISMA 2020 Checklist (.pdf)
]
[
https://jbi.global/sites/default/files/2021-10/Checklist_for_Case_Reports.docx
]
[
https://amstar.ca/Amstar_Checklist.php
]
[
https://www.ohri.ca//programs/clinical_epidemiolo gy/nosgen.pdf
]
[
https://researchintegrityjournal.biomedcentral.com /articles/10.1186/s41073-019-0064-8
]
[
Anis A, Varda M, Dudar A, Schmitz ED. MSSA pericarditis in a patient that was presented with systemic lupus erythematosus flare. Southwest J Pulm Crit Care Sleep. 2022. doi.org/10.13175/swjpccs057-21
]
[
Jethwa H, Rana M, Kitt J, Menzies S, Steuer A. Constrictive pericarditis as the first presentation of systemic lupus erythematosus. Rheumatic Dis Treatment J.2019. 1: 10-12. doi.org/10.33805/2694-2216.104
]
[
Liu D, Li X, Zhang Y, et al. Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis. Drug Des Devel Ther. 2018; 12:1685-1695. Published 2018 Jun 11. doi:10.2147/DDDT.S166893
]
[
Hu S, Lin C, Cai X, et al. The Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis. Mediators Inflamm. 2021; 2021:7712587. Published 2021 Aug 31. doi:10.1155/2021/7712587
]
[
Wakiya R, Kameda T, Nakashima S, et al. Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose. Intern Med. 2020;59(17):2105-2112. doi:10.2169/internalmedicine.4317-19
]
[
Fernandez-Ruiz R, Bornkamp N, Kim MY, et al. Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study. Arthritis Res Ther. 2020;22(1):191. Published 2020 Aug 17. doi:10.1186/s13075-020-02282-0
]
[
Martinez GP, Zabaleta ME, Di Giulio C, Charris JE, Mijares MR. The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases. Curr Pharm Des. 2020;26(35):4467-4485. doi:10.2174/1381612826666200707132920
]
[
Narain S, Berman N, Furie R. Biologics in the treatment of Sjogren's syndrome, systemic lupus erythematosus, and lupus nephritis. Curr Opin Rheumatol. 2020;32(6):609-616. doi:10.1097/BOR.0000000000000754
]
[
Dima A, Jurcut C, Chasset F, Felten R, Arnaud L. Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge. Ther Adv Musculoskelet Dis. 2022; 14:1759720X211073001. Published 2022 Feb 14. doi:10.1177/1759720X211073001
]
[
Clowse MEB, Eudy AM, Balevic S, et al. Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data. Lupus Sci Med. 2022;9(1): e000651. doi:10.1136/lupus-2021-000651
]
[
Floris A, Piga M, Mangoni AA, Bortoluzzi A, Erre GL, Cauli A. Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus. Mediators Inflamm. 2018; 2018:3424136. Published 2018 Feb 18. doi:10.1155/2018/3424136
]
[
Olsen NJ, James JA, Arriens C, et al. Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial. Trials. 2018;19(1):694. Published 2018 Dec 20. doi:10.1186/s13063-018-3076-7
]
[
Li XB, Cao NW, Chu XJ, et al. Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studies. Ann Med. 2021;53(1):1687-1695. doi:10.1080/07853890.2021.1981547
]
[
Cornwell MG, Luttrell-Williams ES, Golpanian M, et al. Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus. Lupus Sci Med. 2021;8(1): e000475. doi:10.1136/lupus-2021-000475
]
[
Vázquez-Otero I, Medina-Cintrón N, Arroyo-Ávila M, González-Sepúlveda L, Vilá LM. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus. Lupus Sci Med. 2020;7(1): e000395. doi:10.1136/lupus-2020-000395
]
[
Virdis A, Tani C, Duranti E, et al. Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus. Arthritis Res Ther. 2015; 17:277. Published 2015 Oct 6. doi:10.1186/s13075-015-0790-3
]
[
Petri M, Konig MF, Li J, Goldman DW. Association of Higher Hydroxychloroquine Blood Levels with Reduced Thrombosis Risk in Systemic Lupus Erythematosus. Arthritis Rheumatol. 2021;73(6):997-1004. doi:10.1002/art.41621
]
[
Jorge A, McCormick N, Lu N, et al. Hydroxychloroquine and Mortality Among Patients with Systemic Lupus Erythematosus in the General Population. Arthritis Care Res (Hoboken). 2021;73(8):1219-1223. doi:10.1002/acr.24255
]